|PDF Version||Genetics of Differentiation - URA 1947 du CNRS|
|Director : Mary C. Weiss (mweiss@pasteur .fr)|
The unit studies the mechanims implicated in the regulation of expression of hepatic genes and in the roles of the transcription factors that are necessary for the establishment and maintenance of hepatic differentiation. In addition, we establish new experimental models of liver cell differentiation and for the study of a key regulatory subunit of cAMP dépendent protein kinase.
The Unit of Genetics of Differentiation uses cell genetics to analyse the roles of different Liver Enriched Transcription Factors (LETF) in the establishment and maintenance of the differentiated hepatic phenotype. It has been shown that in dedifferentiated rat hepatoma cells, the forced expression of HNF4a cDNA is sufficient to provoke the re-expression of genes that are considered markers of hepatic differentiation. In addition, in some cell lines of hepatic origin which fail to express either the LETF or hepatocyte differentiation, the forced expression of either HNF1a or of HNF4a cDNA is sufficient to ensure the expression of the endogenous genes for both factors, indicating the existence of a reciprocal regulatory loop between these two key transcription factors.
At present, our efforts are concentrated on the study of HNF4a, a transcription factor of the nuclear receptor family which has been identified as a key factor for execution of the liver differentiation program. The HNF4a gene has two alternative promoters whose use is regulated during the course of liver development. The protein resulting from use during embryogenesis of the distal promoter, HNF4a7, shows avid transactivation in tranfection tests of genes that are expressed early during development. In contrast, HNF4a1 is produced in abundant fashion only at birth, and this protein shows strong activity on promoters of genes that are expressed neonatally. Thus, the timing of expression and the activity of the two HNF4a isoforms are complementary.
To understand the basis for the differences in transcriptional activity of the HNF4a1 and HNF4a7 isoforms, which differ only in their N-terminal amino acids, the two transactivation domains known for nuclear receptors were analysed using tests of in vitro interaction as well as co-transfection assays. It was found that the region corresponding to the AF-1 of HNF4a7 is devoid of activity while that of HNF4a1 showed the anticipated activity, that was increased by interaction with GRIP and CBP. For both isoforms the AF-2 domain was able to mediate interactions with GRIP-1, p300 and the corepressor SMRT. However, the repression imposed by SMRT was less robust for HNF4a7 than for HNF4a1. Finally, both isofomrs, in association with SMRT, are able to recuite HDAC1 and 4, and when the three molecules are associated, a larger quantity of HNF4a1, but not of HNF4a7, is fixed. Moreover, in a test of transfection in the presence of an inhibitor of HDACs, a dramatic increase of reporter gene activity is observed for HNF4a1 but not HNF4a7. These results imply that HNF4a1, the isoform found in adult liver, is more subject to regulation by interaction with coactivators and corepressors than the HNF4a7 isoform that is present mainly in embryonic and fetal liver.
We have continued to study bipotential cell lines obtained from embyronic liver of the mouse. While the first lines to be studied here were obtained from transgenic mice expressing an activiated form of human c-Met in the liver, our recent attempts to obtain them from non-transgenic mice have been successful. Thus, we now have bipotential liver lines from a large variety of mouse lines. In addition, we have improved the methods for obtaining their differentiation into cholangiocytes and hepatocytes. Hepatocyte functions such as apoloproteins, albumin, AFP, alcohol dehydrogenase and aldolase B are induced upon culture for a few days in the form of aggregates. When cultured in Matrigel, not only are cholangiocyte/oval cell markers such as CD34, c-kit, integrin b4, connexins and GGTIV induced, but morphogenesis into bile duct units is observed. At present, we are using these techniques to analyse the cell lines obtained from mouse embryos carrying targeted mutations in transcription factors important for liver dvelopment. These studies will permit us to clarify the roles of these factors in the maintenance of the bipotential phenotype and in the execution of the cholangoicyte and hepatoctye programmes.
Keywords: Hepatic differentiation, liver-enriched transcription factor, co-regalutor, bipotential cells
|Publications of the unit on Pasteur's references database|
|Office staff||Researchers||Scientific trainees||Other personnel|
|Papelard Solange, firstname.lastname@example.org||WEISS Mary C., IP, CNRS, email@example.com
BAILLY Alain, INSERM, firstname.lastname@example.org
FAUST Daniela, IP, email@example.com
HAYHURST Graham, CNRS, firstname.lastname@example.org
IMAIZUMI-SCHERRER Tereza, CNRS, email@example.com
STRICK Hélène, firstname.lastname@example.org
|BRIANCON Nadège, Ph.D. Student, email@example.com
SLADECK Frances, Sabbatical Professor
|CATHERIN Anne-Marie, IP, firstname.lastname@example.org
DESCHATRETTE Catherine, CNRS,Graduate engineer, email@example.com
MULET Céline, IP, Laboratory research support,